Clinical Trial Update: Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the combination of lithium carbonate and tretinoin in adults with relapsed or refractory acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Lithium carbonate (Lithium carbonate)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: Paolo Caimi, MD | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a) | Phase 1 | Status: COMPLETED